• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

中国与骨髓增生异常综合征相关的染色体畸变的患病率。

The prevalence of chromosomal aberrations associated with myelodysplastic syndromes in China.

作者信息

Hu Qinyong, Chu Yuxin, Song Qibin, Yao Yi, Yang Weihong, Huang Shiang

机构信息

Department of Oncology I, Renmin Hospital, Wuhan University, Road No. 9, Wuhan, China.

Department of Molecular Diagnosis, Kindstar Global, Biolake B3-1, Wuhan, China.

出版信息

Ann Hematol. 2016 Aug;95(8):1241-8. doi: 10.1007/s00277-016-2698-7. Epub 2016 May 25.

DOI:10.1007/s00277-016-2698-7
PMID:27225263
Abstract

This study aims to investigate the prevalence and distribution of diverse chromosomal aberrations associated with myelodysplastic syndromes (MDS) in China. Bone marrow samples were collected from multiple cities in China. Metaphase cytogenetic (MC) analysis and fluorescence in situ hybridization (FISH) were initially used to test chromosomal lesions. Affymetrix CytoScan 750 K genechip platform performed a genome-wide detection of chromosomal aberrations. Chromosomal gain was identified in 76 patients; the most prevalent was trisomy 8(17.9 %). New chromosomal gain was detected on chromosome 9, 19p, and X. Chromosomal loss was detected in 101 patients. The most frequent was loss 5q (21.0 %). Some loss and gain were not identified by MC or FISH but identified by genechip. UPD was solely identified by genechip in 51 patients; the most prevalent were UPD 7q (4.94 %) and UPD 17p (4.32 %). Furthermore, complex chromosomal aberrations were detected in 56 patients. In conclusion, Affymetrix CytoScan 750 K genechip was more precise than MC and FISH in detection of cryptic chromosomal aberrations relevant to MDS. Analysis of the prevalence and distribution of diverse chromosomal aberrations in China may improve strategies for MDS diagnosis and therapies.

摘要

本研究旨在调查中国骨髓增生异常综合征(MDS)相关多种染色体畸变的患病率及分布情况。从中国多个城市采集骨髓样本。最初采用中期细胞遗传学(MC)分析和荧光原位杂交(FISH)检测染色体病变。Affymetrix CytoScan 750K基因芯片平台对染色体畸变进行全基因组检测。76例患者检测到染色体增加;最常见的是8号染色体三体(17.9%)。在9号染色体、19p和X染色体上检测到新的染色体增加。101例患者检测到染色体缺失。最常见的是5q缺失(21.0%)。一些缺失和增加未被MC或FISH检测到,但被基因芯片检测到。51例患者仅通过基因芯片鉴定出单亲二倍体(UPD);最常见的是7q UPD(4.94%)和17p UPD(4.32%)。此外,56例患者检测到复杂染色体畸变。总之,在检测与MDS相关的隐匿性染色体畸变方面,Affymetrix CytoScan 750K基因芯片比MC和FISH更精确。分析中国多种染色体畸变的患病率及分布情况可能会改善MDS的诊断和治疗策略。

相似文献

1
The prevalence of chromosomal aberrations associated with myelodysplastic syndromes in China.中国与骨髓增生异常综合征相关的染色体畸变的患病率。
Ann Hematol. 2016 Aug;95(8):1241-8. doi: 10.1007/s00277-016-2698-7. Epub 2016 May 25.
2
Identify latent chromosomal aberrations relevant to myelodysplastic syndromes.鉴定与骨髓增生异常综合征相关的潜在染色体异常。
Sci Rep. 2017 Sep 4;7(1):10354. doi: 10.1038/s41598-017-10551-3.
3
FISH and SNP-A karyotyping in myelodysplastic syndromes: improving cytogenetic detection of del(5q), monosomy 7, del(7q), trisomy 8 and del(20q).荧光原位杂交和单核苷酸多态性-核型分析在骨髓增生异常综合征中的应用:提高对 del(5q)、单体 7、del(7q)、三体 8 和 del(20q)的细胞遗传学检测。
Leuk Res. 2010 Apr;34(4):447-53. doi: 10.1016/j.leukres.2009.08.023. Epub 2009 Sep 15.
4
[Detecting chromosomal aberrations in myelodysplastic syndrome with fluorescence in situ hybridization and conventional cytogenetic analysis].[运用荧光原位杂交和传统细胞遗传学分析检测骨髓增生异常综合征中的染色体畸变]
Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2014 Jun;39(6):605-11. doi: 10.11817/j.issn.1672-7347.2014.06.010.
5
[Analysis of complex chromosomal aberrations in patients with myelodysplastic syndromes using multiplex fluorescence in situ hybridization combined with whole chromosome painting].[运用多重荧光原位杂交联合全染色体描绘技术分析骨髓增生异常综合征患者的复杂染色体畸变]
Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 2007 Dec;24(6):635-9.
6
Single-nucleotide polymorphism array (SNP-A) improves the identification of chromosomal abnormalities by metaphase cytogenetics in myelodysplastic syndrome.单核苷酸多态性阵列(SNP-A)通过中期细胞遗传学改善了骨髓增生异常综合征中染色体异常的识别。
J Clin Pathol. 2017 May;70(5):435-442. doi: 10.1136/jclinpath-2016-204023. Epub 2016 Nov 11.
7
Combining metaphase cytogenetics with single nucleotide polymorphism arrays can improve the diagnostic yield and identify prognosis more precisely in myelodysplastic syndromes.将中期细胞遗传学与单核苷酸多态性微阵列相结合,可以提高骨髓增生异常综合征的诊断产量,并更准确地识别预后。
Ann Med. 2022 Dec;54(1):2627-2636. doi: 10.1080/07853890.2022.2125173.
8
Cytogenetic aberrations in myelodysplastic syndrome detected by comparative genomic hybridization and fluorescence in situ hybridization.通过比较基因组杂交和荧光原位杂交检测骨髓增生异常综合征中的细胞遗传学异常。
Diagn Mol Pathol. 1999 Mar;8(1):47-53. doi: 10.1097/00019606-199903000-00008.
9
Identification of cytogenetic subclasses and recurring chromosomal aberrations in AML and MDS with complex karyotypes using M-FISH.使用多色荧光原位杂交(M-FISH)鉴定具有复杂核型的急性髓系白血病(AML)和骨髓增生异常综合征(MDS)中的细胞遗传学亚类和复发性染色体畸变。
Genes Chromosomes Cancer. 2002 Jan;33(1):60-72. doi: 10.1002/gcc.1212.
10
Conventional and molecular cytogenetic features of myelodysplastic syndrome in China.中国骨髓增生异常综合征的传统及分子细胞遗传学特征
Exp Oncol. 2007 Dec;29(4):299-303.

引用本文的文献

1
Combining metaphase cytogenetics with single nucleotide polymorphism arrays can improve the diagnostic yield and identify prognosis more precisely in myelodysplastic syndromes.将中期细胞遗传学与单核苷酸多态性微阵列相结合,可以提高骨髓增生异常综合征的诊断产量,并更准确地识别预后。
Ann Med. 2022 Dec;54(1):2627-2636. doi: 10.1080/07853890.2022.2125173.
2
Chromosomal Abnormalities in Myelodysplastic Syndrome Patients in Upper Northern Thailand.泰国北部上游地区骨髓增生异常综合征患者的染色体异常
Asian Pac J Cancer Prev. 2020 Mar 1;21(3):639-645. doi: 10.31557/APJCP.2020.21.3.639.
3
Techniques for detecting chromosomal aberrations in myelodysplastic syndromes.
检测骨髓增生异常综合征中染色体畸变的技术。
Oncotarget. 2017 May 9;8(37):62716-62729. doi: 10.18632/oncotarget.17698. eCollection 2017 Sep 22.
4
Identify latent chromosomal aberrations relevant to myelodysplastic syndromes.鉴定与骨髓增生异常综合征相关的潜在染色体异常。
Sci Rep. 2017 Sep 4;7(1):10354. doi: 10.1038/s41598-017-10551-3.